He answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.
Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while...
